Moderna skyrockets 29% after its early trial for a coronavirus vaccine produced antibodies in all 45 patients (MRNA)

Moderna skyrockets 29% after its early trial for a coronavirus vaccine produced antibodies in all 45 patients (MRNA)

Business Insider

Published

**

· *Moderna announced on Monday that its early trial for its coronavirus vaccine produced antibodies in all patients. *
· *Shares of the company surged 29% on Monday. *
· *The company is aiming to have the vaccine ready for emergency use in the fall.*
· *Watch Moderna trade live on Markets Insider.*
· *Read more...

Full Article